June 2, 2000 -- For five years, antidepressant drugs have redefined daily
life for Carla, a graphic designer in Des Moines, Iowa. They've helped her pry
loose from depression so powerful she could barely get out of bed in the
morning. They've helped her raise three teenage sons and put an end to her
occasional thoughts of suicide.
But such help has come at a price -- a price some doctors are starting to
question. Twelve years after Prozac first hit the market, a growing chorus of
psychiatrists claims that America is becoming an overmedicated society,
reaching for prescriptions at the first sign of mild depression -- and risking
potentially dangerous side effects in the process.
While some people look forward to the brisk days of fall and winter,
anticipating family dinners and cozy nights by the fire, others dread the
cooler temperatures and shorter days.
If history repeats, they know that the winter season will bring, like
clockwork, worsening symptoms of depression.
Up to 3% of the population in the U.S. may suffer from winter depression,
which experts term seasonal affective disorder, or SAD.
Some of the 6.7% Americans who suffer depression year-round find...
Like Carla, one in eight Americans have taken one of the popular new class
of antidepressants called selective serotonin reuptake inhibitors, according to
an ABC News survey done in April. Better known by the brand names Prozac,
Paxil, Zoloft, or Luvox, these drugs are thought to boost brain levels of the
chemical serotonin and to quell an array of emotional disorders, from
depression to panic to anxiety. Indeed, the drugs are so popular that an
estimated 28 million Americans -- one in 10 -- currently use them. To date,
over 60 million prescriptions for this class of drug have been written. That's
a stunningly high figure considering that the National Mental Health
Association estimates that only 19 million Americans suffer from severe
Stephen Crystal, PhD, a Rutgers researcher who studies prescription trends,
calls it a "massive uncontrolled experiment," in which doctors are
handing their patients prescriptions when they haven't even been diagnosed with
a mental disorder in the first place. Equally troubling, the ABC News survey
found that nearly half of people on the new antidepressants have taken the
drugs for a year or more, even though these drugs haven't been tested for
Leading the dissent is Harvard psychiatrist Joseph Glenmullen, MD, author of
Prozac Backlash. Glenmullen argues that as many as 75% of patients are
on antidepressants for mild -- even trivial -- conditions. For many of these
people, he says, the risk-benefit ratio of taking antidepressants is simply